Outset Medical, Inc. (OM) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 97.65M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 242.38M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $97.65M | (m) | (m) | $242.38M | (m) |
| 2026-03-31 | (m) | (m) | (m) | $96.94M | (m) | (m) | $249.45M | (m) |
| 2025-12-31 | (m) | (m) | (m) | $96.24M | (m) | (m) | $264.50M | (m) |
| 2025-09-30 | (m) | (m) | (m) | $95.52M | (m) | (m) | $277.25M | (m) |
| 2025-06-30 | (m) | (m) | (m) | $94.81M | (m) | $106.31M | $288.80M | (m) |
| 2025-03-31 | (m) | (m) | (m) | $94.11M | (m) | $86.44M | $301.21M | (m) |
| 2024-12-31 | (m) | (m) | (m) | $197.38M | (m) | $127.01M | $275.80M | (m) |
| 2024-09-30 | (m) | (m) | (m) | $197.18M | (m) | $35.95M | $292.89M | (m) |
| 2024-06-30 | (m) | (m) | (m) | $196.99M | (m) | $167.99M | $314.53M | (m) |
| 2024-03-31 | (m) | (m) | (m) | $196.81M | (m) | $190.07M | $346.24M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $130.11M | (m) | $133.39M | $313.80M | (m) |
| 2023-09-30 | (m) | (m) | (m) | $96.78M | (m) | $128.94M | $307.55M | (m) |
| 2023-06-30 | (m) | (m) | (m) | $96.63M | (m) | $175.20M | $334.44M | (m) |
| 2023-03-31 | (m) | (m) | (m) | $96.48M | (m) | $123.80M | $362.67M | (m) |
| 2022-12-31 | (m) | (m) | (m) | $96.34M | (m) | (m) | $400.12M | (m) |
| 2022-09-30 | (m) | (m) | (m) | $29.83M | (m) | (m) | $365.72M | (m) |
| 2022-06-30 | (m) | (m) | $1.00M | $28.81M | (m) | (m) | $401.24M | (m) |
| 2022-03-31 | (m) | (m) | (m) | $29.78M | (m) | (m) | $431.74M | (m) |
| 2021-12-31 | (m) | (m) | (m) | $29.76M | (m) | (m) | $463.46M | (m) |
| 2021-09-30 | (m) | (m) | (m) | $29.74M | (m) | (m) | $488.80M | (m) |
| 2021-06-30 | (m) | (m) | (m) | $29.72M | (m) | (m) | $504.81M | (m) |
| 2021-03-31 | (m) | (m) | (m) | $29.70M | (m) | (m) | $379.83M | (m) |
| 2020-12-31 | (m) | (m) | (m) | $29.67M | (m) | (m) | $403.83M | (m) |
| 2020-09-30 | (m) | (m) | (m) | $29.65M | (m) | (m) | $426.02M | (m) |
| 2019-12-31 | (m) | (m) | $7.50M | $21.56M | (m) | (m) | $88.37M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |